15.07.2024
|
Start of a review concerning the conduct of studies at Synapse Labs Pvt. Ltd., India
Active substance: various
The Federal Institute for Drugs and Medical Devices (BfArM) implements the decision of the European Commission of 24 May 2024 for the German marketing authorisations with its decision of 17 June 2024.
|